Nadine Kasparian

Nadine Kasparian

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2022 in Psycho-Oncology
Verified
Journal Article
Open access
YLYvonne L. Luigjes‐Huizer
Yvonne L. Luigjes‐Huizer
NTNina M. Tauber
Nina M. Tauber
Gerald HumphrisGerald Humphris
Gerald Humphris
NKNadine Kasparian
Nadine Kasparian
WLWendy W. T. Lam
Wendy W. T. Lam
MLMarije L. van der Lee
Marije L. van der Lee
Objective: Care for fear of cancer recurrence (FCR) is considered the most common unmet need among cancer survivors. Yet the prevalence of FCR and predisposing factors remain inconclusive. To support targeted care, we provide a comprehensive overview of the prevalence and severity of FCR among cancer survivors and patients, as measured using the short form of the validated Fear of Cancer Recurrence Inventory (FCRI‐SF). We also report on associations between FCR and clinical and demographic characteristics.Methods: This is a systematic review and individual participant data (IPD) meta‐analysis on the prevalence of FCR. In the review, we included all studies that used the FCRI‐SF with adult (≥18 years) cancer survivors and patients. Date of search: 7 February 2020. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tool.Results: IPD were requested from 87 unique studies and provided for 46 studies comprising 11,226 participants from 13 countries. 9311 respondents were included for the main analyses. On the FCRI‐SF (range 0–36), 58.8% of respondents scored ≥13, 45.1% scored ≥16 and 19.2% scored ≥22. FCR decreased with age and women reported more FCR than men. FCR was found across cancer types and continents and for all time periods since cancer diagnosis.Conclusions: FCR affects a considerable number of cancer survivors and patients. It is therefore important that healthcare providers discuss this issue with their patients and provide treatment when needed. Further research is needed to investigate how best to prevent and treat FCR and to identify other factors associated with FCR.The protocol was prospectively registered (PROSPERO CRD42020142185).

12 June 2009 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
NKNadine Kasparian
Nadine Kasparian
JMJordana McLoone
Jordana McLoone
BMBettina Meiser
Bettina Meiser

1 December 2009 in Archives of Dermatology
Verified
Journal Article
Open access
PDF file
NKNadine Kasparian
Nadine Kasparian
JMJordana McLoone
Jordana McLoone
PBPhyllis N. Butow
Phyllis N. Butow
Despite continued progress in the medical management of many malignant diseases, the diagnosis of cancer, including melanoma, remains a difficult event in the lives of many patients and their families. Clinical impressions and research findings suggest that a diagnosis of melanoma has the potential to change all aspects of an individual's daily living from self-identity, body image, and perceived well-being, to family roles and relationships, career opportunities, friendships, and finances.1,2 The distress evoked by such changes may have wide-ranging implications. Psychological distress has been associated with patient delay in seeking medical advice for melanoma, decreased adherence to treatment regimes, increased rates of melanoma recurrence and mortality, lower quality of life (QOL), increased medical costs, and reduced engagement in posttreatment skin cancer screening and preventive behaviors.3-5 Thus, understanding the prevalence and correlates of psychological distress and developing interventions to reduce distress remain critical research and clinical endeavors.

20 December 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
MDMbathio Dieng
Mbathio Dieng
PBPhyllis N. Butow
Phyllis N. Butow
DCDaniel S.J. Costa
Daniel S.J. Costa
RMRachael L. Morton
Rachael L. Morton
SMScott W. Menzies
Scott W. Menzies
NKNadine Kasparian
Nadine Kasparian
Purpose: People with a history of melanoma commonly report a fear of cancer recurrence (FCR), yet psychologic support is not routinely offered as part of ongoing melanoma care. This randomized controlled trial examined the efficacy of a psychoeducational intervention to reduce FCR and improve psychologic adjustment in this patient group compared with usual care. Methods: The intervention comprised a newly developed psychoeducational resource and three telephone-based psychotherapeutic sessions over a 1-month period timed in accordance with dermatologic appointments. Participants were randomly assigned to intervention (n = 80) or usual care (n = 84). Assessments were completed at baseline, 1 month, and 6 months after dermatologic appointments. Linear mixed models were used to examine differences between treatment and control groups for patient-reported outcomes, including FCR, anxiety, stress, depression, melanoma-related knowledge, health behaviors, satisfaction with melanoma care, unmet needs, and health-related quality of life. Results: At 6 months, the intervention group reported lower FCR severity, trigger, and distress scores than the control group in the baseline-adjusted models; the between-group mean difference was −1.9 for FCR severity (95% CI, −3.1 to −0.7; P = .002), −2.0 for FCR triggers (95% CI, −3.3 to −0.7; P = .003), and −0.7 for FCR distress (95% CI, −1.3 to −0.1; P = .03). The decrease in FCR severity (but not triggers or distress) remained statistically significant after adjustment for other covariates ( P = .04). At 6 months, the intervention group also reported lower stress (−1.6; 95% CI, −3.1 to −0.2; P = .03) and improved melanoma-related knowledge (1.7; 95% CI, 0.8 to 2.6; P < .001) compared with the control group. No differences were found between groups for other secondary outcomes. Conclusion: This newly developed evidence-based psychoeducational intervention was effective in reducing FCR and stress and increasing melanoma-related knowledge in people at high risk for another melanoma.

1 September 2010 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
RBRichard Bränström
Richard Bränström
NKNadine Kasparian
Nadine Kasparian
YCYu-Mei Chang
Yu-Mei Chang
PAPaul Affleck
Paul Affleck
ATAad Tibben
Aad Tibben
YBYvonne Brandberg
Yvonne Brandberg
Background: The incidence of melanoma continues to increase in many countries, and primary prevention of melanoma includes avoidance of sunburn as well as adequate sun protection behavior. The aim of this study was to examine the prevalence of self-reported sun protection behaviors and sunburn in users of the Internet, and to identify the demographic, clinical, and attitudinal/motivational correlates of sun protection behaviors. Methods: Self-report data were gathered on behalf of the GenoMEL consortium using an online survey available in 10 different languages, and 8,178 individuals successfully completed at least 80% of survey items, with 73% of respondents from Europe, 12% from Australia, 7% from the United States, 2% from Israel, and 6% from other countries. Results: Half of all respondents and 27% of those with a previous melanoma reported at least one severe sunburn during the previous 12 months. The strongest factors associated with sun protection behavior were perceived barriers to protection (β = −0.44/β = −0.37), and respondents who reported a positive attitude toward suntans were less likely to protect (β = −0.16/β = −0.14). Reported use of protective clothing and shade, as well as avoidance of midday sun exposure, were more strongly related to reduced risk of sunburn than sunscreen use. Conclusions: Despite widespread dissemination of public health messages about the importance of sun protection, a substantial proportion of this international sample, including respondents with a previous melanoma, reported inadequate sun protection behaviors resulting in severe sunburn. Impact: Future strategies to decrease sunburn should target the practical, social, and psychological barriers associated with nonuptake of sun protection. Cancer Epidemiol Biomarkers Prev; 19(9); 2199–210. ©2010 AACR.

3 June 2016 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
SMSarah Marokakis
Sarah Marokakis
NKNadine Kasparian
Nadine Kasparian
SKSean E Kennedy
Sean E Kennedy